What is the estimated annual risk of developing lung cancer for a never-smoker (non-smoker) with an average radon level of 4 picoCuries per liter (pCi/L) at home?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Radon Exposure at 4 pCi/L and Lung Cancer Risk in Never-Smokers

For a never-smoker with average home radon levels of 4 pCi/L, the excess relative risk of lung cancer is approximately 15% per 100 Bq/m³ (roughly 2.7 pCi/L), translating to an estimated 20-25% increased risk at 4 pCi/L compared to minimal radon exposure. 1, 2

Quantified Risk Estimates

The most robust evidence comes from a 2021 systematic review and meta-analysis specifically examining never-smokers, which pooled data from 2,341 never-smoker lung cancer cases and 8,967 never-smoker controls 2:

  • Adjusted excess relative risk (aERR) per 100 Bq/m³: 0.15 (95% CI 0.06-0.25) for never-smokers 2
  • Converting to pCi/L units: 100 Bq/m³ ≈ 2.7 pCi/L
  • At 4 pCi/L (approximately 148 Bq/m³), this translates to roughly 1.22 times baseline risk (22% increase)

A large Swedish study of 436 never-smoking lung cancer cases found similar estimates, reporting 10% excess relative risk per 100 Bq/m³, with relative risks of 1.08,1.18, and 1.44 for radon categories below 50-80-140, and above 140 Bq/m³ respectively 1. Your 4 pCi/L exposure (≈148 Bq/m³) falls into the higher risk category.

Clinical Context and Absolute Risk

While the relative risk increase is meaningful, absolute risk remains important to contextualize 3:

  • NCCN guidelines note that residential radon shows a linear relationship with lung cancer risk, though the association is weaker than occupational uranium miner exposures 3
  • The EPA action level of 4 pCi/L is based on an estimated 15,000-20,000 annual lung cancer deaths in the U.S. from residential radon 4
  • Never-smokers represent approximately 10-15% of all lung cancer cases, with radon being a leading risk factor in this population 5, 2

Important Sex-Based Differences

Men who are never-smokers face significantly higher radon-related lung cancer risk than women 2:

  • aERR per 100 Bq/m³ for never-smoking men: 0.46 (95% CI 0.15-0.76)
  • aERR per 100 Bq/m³ for never-smoking women: 0.09 (95% CI -0.02-0.20)
  • This difference was statistically significant (p=0.027) 2

If you are male, your risk at 4 pCi/L may be approximately 3-fold higher than the average never-smoker estimate.

Critical Mitigation Recommendation

At 4 pCi/L, you are at the EPA action level where mitigation is recommended 4:

  • Radon exposures can be prevented through basement sealing or ventilation 4
  • Various methods are available for indoor radon reduction when testing shows levels at or above 4 pCi/L 4
  • Mitigation is particularly important given that higher indoor radon exposure has been associated with worse survival outcomes even after lung cancer diagnosis 6

Comparison to Other Risk Factors

To contextualize this risk 3, 5:

  • Secondhand smoke exposure: RR 1.24 (24% increase) 5
  • Occupational carcinogen exposure: mean RR 1.59 (59% increase) 3
  • First-degree family history of lung cancer: RR 1.8 (80% increase) 3
  • Your radon exposure at 4 pCi/L (20-25% increase) is comparable to secondhand smoke exposure

Methodological Limitations

The evidence has important caveats 7, 8:

  • Most individual residential radon studies have limited sample sizes of never-smokers, reducing statistical power 7
  • Cumulative radon exposure estimation involves measurement uncertainty across multiple residences 8
  • The 2005 meta-analysis cited by NCCN guidelines showed RR 1.14 (95% CI 1.0-1.3) for residential radon overall, with confidence intervals barely excluding no effect 3
  • However, the more recent 2021 meta-analysis focused specifically on never-smokers provides stronger evidence with tighter confidence intervals 2

References

Research

Residential radon and lung cancer among never-smokers in Sweden.

Epidemiology (Cambridge, Mass.), 2001

Research

Systematic review and meta-analysis of residential radon and lung cancer in never-smokers.

European respiratory review : an official journal of the European Respiratory Society, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Radon Exposure and Lung Cancer Risk

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Lung Cancer in Never-Smokers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.